The group now has 325 approvals and has so far filed over 400 ANDAs since the commencement of the filing process in FY 2003-04.
Brii Bio announces amubarvimab/romlusevimab combination received approval from NMPA
The product will be commercialized from Unichem's Ghaziabad plant
She replaces Victoria Tabiner, who is stepping down after 10 years at Sygnature
_256_384.jpg)
Destiny-Breast11 will evaluate Enhertu as a monotherapy or Enhertu followed by paclitaxel, trastuzumab and pertuzumab
The main objective of successive rounds of the NFHS is to provide reliable and comparable data relating to health and family welfare and other emerging issues
While industry steps out of its comfort zone to innovate, the government has to support by allocating funds across research lifecycle and offer incentives for innovation
CStone granted the exclusive rights to Hengrui for research, development, registration, manufacturing, and commercialization of anti-CTLA-4 mAb CS1002 in the Greater China region
Suchirayu owns a state-of-the-art multi-speciality hospital in Hubli with an operational capacity of 110 beds and a potential to scale up to 250 beds
First-of-its-kind Incubator will support companies poised to deliver breakthrough applications in genomics and multiomics
Subscribe To Our Newsletter & Stay Updated
